ACTA Trial of the Year Award Winner
The 2025 ACTA Trial of the Year Award was awarded to the PLUSS trial, recognising a groundbreaking study that could transform care for extremely preterm infants.
Led by Professor Brett Manley and conducted under the IMPACT Network, the trial investigated whether giving intra-tracheal budesonide with surfactant could reduce the risk of bronchopulmonary dysplasia (BPD)—a serious lung condition in premature babies. Conducted across 21 hospitals in Australia, New Zealand, Singapore, and Canada, the study enrolled over 1,000 infants and showed promising results.
Read more about the awards on the ACTA website.
Impact Report 2025
We’re proud to share Bellberry’s 2025 Impact Report - our first report bringing together key insights, data and achievements from the past…
Read More
Bellberry Office Easter Closure 2026
The Bellberry office will be closed for the Easter break on Friday 3 April and Monday 6 April. Reopening at 9am on…
Read More
2026 Podcast Season: More About NAMs
When a potential new medicine is tested on humans for the first time it is a milestone. It is thoroughly tested for…
Read More
Bellberry Newsletter – Summer 2025
Welcome to our newsletter for summer 2025. The Bell contains a roundup of the activities Bellberry has been involved with in the…
Read More
2025-26 Meeting & Submission Dates
Our end of year meeting and submission dates are as follows: The Bellberry office will be closed from COB Wed 24 December…
Read More
Project Officer Vacancy
Project Officer - Adelaide, Full time We're seeking a Project Officer with strong auditing and governance experience to help deliver services that…
Read More
2025/26 Bellberry-Viertel Fellow Announced
Last month at the Australian Academy of Health and Medical Sciences Gala Dinner in Canberra our new Bellberry-Viertel Fellow was announced! Congratulations…
Read More
2025-26 Meeting & Submission Dates
Our end of year meeting and submission dates are as follows: The Bellberry office will be closed from COB Wed 24 December…
Read More
National Statement Updates 2025
The National Statement on Ethical Conduct in Human Research is the principal reference for research involving humans in Australia and is the…
Read More
Operations Update 28
In the September issue of our Operations Update please find articles on: New Bellberry office address New eProtocol registrations contact email Bellberry…
Read More
Bellberry User Satisfaction Survey
As Australia’s largest provider of Human Research Ethics Committee services, Bellberry places great value on understanding the experience our users have of…
Read More
International Research Administrators Day
Today, September 25, we celebrate International Research Administrators Day! This globally recognised day honours the contribution of Research Administrators in supporting and…
Read More
NAMs workshop summary report released
We are pleased to release the summary report from the Bellberry & ASCEPT New Approach Methodologies (NAMs) Introductory Workshop, held in Melbourne,…
Read More
Clinical Trial Activity Report (CTAR) 2024
Report highlights international confidence in Australian clinical trials Global investment in Australian clinical trials is strong, with two thirds of Australian clinical…
Read More
Podcast Episode 12: From Lab to Life
Worldwide there is growing focus on using NAMs (Non-Animal Models also known as Novel Approach Methods) in the development of therapeutics. In…
Read More